Literature DB >> 10631365

Interleukin-10 protects against lethality of intra-abdominal infection and sepsis.

A J Rongione1, A M Kusske, K Kwan, S W Ashley, H A Reber, D W McFadden.   

Abstract

The aim of this study was to determine whether interleukin-10 would alter locally derived and systemic proinflammatory cytokine expression and protect from the lethality of cecal ligation and puncture. Three groups of Sprague-Dawley rats were used. Group 1 underwent cecal manipulation. Groups 2 and 3 underwent cecal ligation and puncture. Group 2 received intraperitoneal saline injections beginning 1 hour after cecal ligation and puncture and every 3 hours thereafter for 24 hours. Group 3 received intraperitoneal interleukin-10 one hour after cecal ligation and puncture and every 3 hours thereafter. Animals were killed at 6 and 24 hours after cecal ligation and puncture or sham operation. Serum tumor necrosis factor-alpha (TNF-alpha) levels were determined by enzyme-linked immunosorbent assay. TNF-alpha messenger RNA expression was determined by reverse transcriptase-polymerase chain reaction using Beta-actin as the internal standard. There was a twofold increase (P <0.001) in TNF-alpha mRNA in the liver at 6 and 24 hours after cecal ligation and puncture when compared to rats treated with interleukin-10. There was a twofold increase (P <0.05) in TNF-alpha mRNA in the lung observed only at 24 hours after cecal ligation and puncture when compared to rats treated with interleukin-10. Serum levels of TNF-alpha were elevated at 6 hours in control animals, and this effect was abolished by the administration of interleukin-10. There was no difference in mortality rates at 6 hours (0% for all groups); however, at 24 hours 57% (4/7) mortality was observed in group 2 vs. 0% (0/20) in groups 1 and 3. Interleukin-10 given after the onset of cecal ligation and puncture protects against the lethality of intra-abdominal sepsis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10631365     DOI: 10.1016/s1091-255x(00)80035-9

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  30 in total

1.  Identification of an inducible endothelial-leukocyte adhesion molecule.

Authors:  M P Bevilacqua; J S Pober; D L Mendrick; R S Cotran; M A Gimbrone
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

Review 2.  Sepsis and septic shock--a review of laboratory models and a proposal.

Authors:  K A Wichterman; A E Baue; I H Chaudry
Journal:  J Surg Res       Date:  1980-08       Impact factor: 2.192

3.  Plasma tumor necrosis factor levels in patients with presumed sepsis. Results in those treated with antilipid A antibody vs placebo.

Authors:  M A de Groote; M A Martin; P Densen; M A Pfaller; R P Wenzel
Journal:  JAMA       Date:  1989-07-14       Impact factor: 56.272

4.  Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin.

Authors:  B Beutler; I W Milsark; A C Cerami
Journal:  Science       Date:  1985-08-30       Impact factor: 47.728

5.  Regulation of macrophage TNF alpha, IL-1 beta, and Ia (I-A alpha) mRNA expression during peritonitis is site dependent.

Authors:  K M McMasters; W G Cheadle
Journal:  J Surg Res       Date:  1993-05       Impact factor: 2.192

6.  Divergent efficacy of antibody to tumor necrosis factor-alpha in intravascular and peritonitis models of sepsis.

Authors:  G J Bagby; K J Plessala; L A Wilson; J J Thompson; S Nelson
Journal:  J Infect Dis       Date:  1991-01       Impact factor: 5.226

Review 7.  The pathogenesis of sepsis.

Authors:  R C Bone
Journal:  Ann Intern Med       Date:  1991-09-15       Impact factor: 25.391

8.  Tissue tumor necrosis factor mRNA expression following cecal ligation and puncture or intraperitoneal injection of endotoxin.

Authors:  D J Hadjiminas; K M McMasters; J C Peyton; W G Cheadle
Journal:  J Surg Res       Date:  1994-06       Impact factor: 2.192

9.  Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog.

Authors:  K J Tracey; S F Lowry; T J Fahey; J D Albert; Y Fong; D Hesse; B Beutler; K R Manogue; S Calvano; H Wei
Journal:  Surg Gynecol Obstet       Date:  1987-05

10.  Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia.

Authors:  C Gérard; C Bruyns; A Marchant; D Abramowicz; P Vandenabeele; A Delvaux; W Fiers; M Goldman; T Velu
Journal:  J Exp Med       Date:  1993-02-01       Impact factor: 14.307

View more
  6 in total

1.  Inflammatory response and bacterial dissemination after laparotomy and abdominal CO2 insufflation in a murine model of peritonitis.

Authors:  M B Pitombo; O H Lupi; R N Gomes; R Amâncio; R A Refinetti; P T Bozza; H C Castro-Faria-Neto
Journal:  Surg Endosc       Date:  2006-05-15       Impact factor: 4.584

2.  Role of the mTOR pathway in LPS-activated monocytes: influence of hypertonic saline.

Authors:  Valérie Schaeffer; Saman Arbabi; Iris A Garcia; Megan L Knoll; Joseph Cuschieri; Eileen M Bulger; Ronald V Maier
Journal:  J Surg Res       Date:  2010-06-09       Impact factor: 2.192

3.  Carbon dioxide pneumoperitoneum prevents mortality from sepsis.

Authors:  E J Hanly; J M Fuentes; A R Aurora; S L Bachman; A De Maio; M R Marohn; M A Talamini
Journal:  Surg Endosc       Date:  2006-07-24       Impact factor: 4.584

4.  A comparative study of angiogenic and cytokine responses after laparoscopic cholecystectomy performed with standard- and low-pressure pneumoperitoneum.

Authors:  Kamil Torres; Anna Torres; Grzegorz J Staśkiewicz; Andrzej Chrościcki; Tadeusz Loś; Ryszard Maciejewski
Journal:  Surg Endosc       Date:  2008-12-06       Impact factor: 4.584

5.  Cytokine response in the postoperative period after surgical treatment of benign adnexal masses: comparison between laparoscopy and laparotomy.

Authors:  A Torres; K Torres; T Paszkowski; G J Staśkiewicz; R Maciejewski
Journal:  Surg Endosc       Date:  2007-03-14       Impact factor: 3.453

6.  Cytokines and signaling molecules predict clinical outcomes in sepsis.

Authors:  Christopher D Fjell; Simone Thair; Joseph L Hsu; Keith R Walley; James A Russell; John Boyd
Journal:  PLoS One       Date:  2013-11-14       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.